Oddo BHF - Morning CrÃ©dit 20/12/2017

Report

Oddo BHF

Carole Braudeau

Morning CrÃ©dit 20/12/2017

Les crÃ©anciers de Oi approuvent le plan de restructuration de la dette.Iliad et NJJ vont acquÃ©rir une participation majoritaire dans Eir.Les actionnaires de Stada ont franchi une Ã©tape majeure dans le projet dâ€™accord de domination>

20/12/2017 15 FR

Provider

Oddo BHF

Oddo Securities provides securities brokerage and research services. The company offers equity, economic, and derivatives research and credit analysis services. It focuses on insurance, automotive, building materials, pharmaceuticals, telecommunications, information technology, and agri-food industries.

See profile

Analysts

Carole Braudeau

Other Reports from Oddo BHF

Michael B. Schäfer

Michael B. Schäfer

Evonik Industries AG : Final Q3 EBITDA € 448m in line with prelim range; good OpFCF catch-up; lowered EBITDA 2025 outlook of 'around € 1.9bn' reiterated (css € 1.88bn)

3m 3m 1 EN

Oliver Metzger

Oliver Metzger

Coloplast : Q4 review – Results and guidance in line with expectations

3m 3m 1 EN

Olfa Taamallah ... (+2)

Olfa Taamallah
Yan Derocles

Ryanair : A broadly favourable environment

3m 3m 1 EN

Sign-up for free to access full reports immediately

Email Address*

Choose Password* ( 6 or more characters )

Due to regulatory restrictions regarding the distribution of financial research, this report is restricted to a specific region or investor type. Get access to exclusive reports by answering the questions below.

Select your country*

Get financial insights straight to your inbox

By clicking "register" you accept the Terms and Conditions & Privacy Policy

Already on ResearchPool?

Almost there...

Are you a professional investor?

Select your country

REGISTER

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

In order to access this report please create an account.

LOGIN

Morning CrÃ©dit 20/12/2017

Evonik Industries AG : Final Q3 EBITDA € 448m in line with prelim range; good OpFCF catch-up; lowered EBITDA 2025 outlook of 'around € 1.9bn' reiterated (css € 1.88bn)

Coloplast : Q4 review – Results and guidance in line with expectations

Ryanair : A broadly favourable environment

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

Sign-up for free to access full reports immediately

ResearchPool Subscriptions

Get the most out of your insights

Why subscribe?

How to subscribe

ResearchPool Subscriptions

This report is only available to subscribers

Why subscribe?

How to subscribe